← Leaderboards
John H Rex
University Of Texas Hlth Sci Ctr Houston
$41,356
Attributed
$41,356
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$41,356 · 3
By mechanism
M01$41,356 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Michael C Lorenz$12,581,222
- Danielle A Garsin$10,870,643
- Jose Christian Perez$1,424,056
- Philip C Johnson$60,456
- Scott M Drouin$1,831,167
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectCandidiasisMicroorganism Disease ChemotherapyDrug Screening /EvaluationAntifungal AgentsHuman Therapy EvaluationClinical TrialsEsophagus DisorderIntravenous AdministrationGlycopeptidesGlucansAspergillusCandidaPneumocystisClinical Trial Phase IPharmacokineticsDrug Administration Rate /DurationAidsCandida AlbicansClinical ResearchOpportunistic InfectionsDrug ResistanceAmphotericin BDosage
Grant awards (5)
LY303366 (IV) PILOT STUDY FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2002 · RR
LY303366 (IV) PILOT STUDY FOR ESOPHAGEAL CANDIDIASIS$0
M01 · FY2001 · RR
L-743,872 VS AMPHOTERICIN B TREATMENT OF OROPHARYNGEAL &ESOPHAGEAL CANDIDIASIS$15,114
M01 · FY2000 · RR
OPEN SERIAL PANEL STUDY OF L-743,872 IN PATIENTS WITH CANDIDA ESOPHAGITIS$15,114
M01 · FY2000 · RR
LY303366 (IV) PILOT STUDY FOR ESOPHAGEAL CANDIDIASIS$11,128
M01 · FY2000 · RR